Reaction
Antibody Test Positive reporting signals
As of the last recalculation, Antibody Test Positive appears in 1,658 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 207.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 235 | 207.0 | 210.0 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 127 | 73.7 | 74.1 |
| Naproxen Sodium Tablet, Coated | 69 | 66.7 | 67.0 |
| Naproxen Sodium, Coated Tablets | 69 | 66.7 | 67.0 |
| Naproxen Sodium 220Mg | 69 | 66.6 | 66.9 |
| Triamcinolone Acetonide | 128 | 56.3 | 56.5 |
| Adalimumab-Fkjp | 177 | 53.6 | 53.8 |
| Adalimumab-Aaty | 177 | 52.4 | 52.6 |
| Sulfasalazine | 273 | 52.2 | 52.4 |
| Agalsidase Beta | 35 | 48.5 | 48.7 |
| Adalimumab-Adaz | 180 | 47.9 | 48.1 |
| Human Immunoglobulin G | 71 | 45.1 | 45.2 |
| Tocilizumab | 269 | 35.1 | 35.2 |
| Naproxen | 189 | 34.0 | 34.0 |
| Infliximab | 388 | 28.8 | 28.9 |
| Hydroxychloroquine | 154 | 28.4 | 28.5 |
| Hydroxychloroquine Sulfate | 177 | 27.2 | 27.2 |
| Abatacept | 234 | 24.5 | 24.6 |
| Naproxen Sodium | 216 | 21.7 | 21.7 |
| Natalizumab | 210 | 16.5 | 16.5 |
| Basiliximab | 12 | 12.9 | 12.9 |
| Anti-Thymocyte Globulin (Rabbit) | 8 | 12.5 | 12.5 |
| Heparin Sodium | 13 | 12.0 | 12.0 |
| Romiplostim | 14 | 11.8 | 11.8 |
| Methotrexate | 303 | 10.8 | 10.8 |
| Methotrexate Sodium | 322 | 10.1 | 10.1 |
| Adalimumab | 355 | 7.7 | 7.7 |
| Interferon Beta-1B | 11 | 7.2 | 7.2 |
| Etanercept | 290 | 7.2 | 7.2 |
| Busulfan | 7 | 5.6 | 5.6 |
| Temozolomide | 7 | 4.2 | 4.2 |